Ascentage Pharma Group International (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

24.05

-0.35 (-1.43%)

At close: Mar 18, 2026, 4:00 PM EDT

22.10

-1.95 (-8.11%)

Pre-market: Mar 19, 2026, 8:32 AM EDT

AAPG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	2,236	-	-	-	-	-
Market Cap Growth	27.62%	-	-	-	-	-
Enterprise Value	2,243	0	0	0	0	0
Debt / Equity Ratio	2.54	6.09	25.42	4.39	0.88	0.63
Debt / EBITDA Ratio	-1.48	-5.66	-2.23	-2.14	-1.13	-0.77
Debt / FCF Ratio	-	-12.30	-2.33	-2.09	-1.04	-0.62
Net Debt / Equity Ratio	0.08	1.54	11.62	0.74	-0.53	-0.58
Net Debt / EBITDA Ratio	-0.05	-1.38	-0.87	-0.36	0.69	0.72
Net Debt / FCF Ratio	-	-3.00	-0.91	-0.35	0.63	0.57
Asset Turnover	0.14	0.38	0.08	0.07	0.01	0.01
Inventory Turnover	4.70	2.56	2.38	3.29	1.69	-
Quick Ratio	1.53	1.26	1.42	1.85	5.21	3.91
Current Ratio	1.54	1.26	1.44	1.86	5.22	3.91
Return on Equity (ROE)	-124.37%	-235.32%	-386.28%	-107.45%	-75.18%	-78.02%
Return on Assets (ROA)	-41.45%	-15.56%	-33.40%	-31.08%	-39.59%	-48.82%
Return on Invested Capital (ROIC)	-116.04%	-37.32%	-83.61%	-92.76%	-129.70%	-202.62%
Return on Capital Employed (ROCE)	-71.39%	-25.71%	-51.04%	-39.80%	-48.77%	-58.14%

Updated Sep 19, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q